Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORCH
2024-514927-40-02Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Chronic subdural haematoma (CSDH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Need for surgery for chronic subdural hematoma within 12 weeks. Planned start Sep 2024; status: authorised.
02
Drugs
tranexamic acid
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on 2024-514927-40-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514927-40-02.